Alicia Hager
2017 - OncoMed Pharmaceuticals
In 2017, Alicia Hager earned a total compensation of $1.4M as Senior Vice President and General Counsel at OncoMed Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $125,143 |
|---|---|
| Option Awards | $804,964 |
| Salary | $347,619 |
| Stock Awards | $154,536 |
| Total | $1,432,262 |
Hager received $805K in option awards, accounting for 56% of the total pay in 2017.
Hager also received $125.1K in non-equity incentive plan, $347.6K in salary and $154.5K in stock awards.
Rankings
In 2017, Alicia Hager's compensation ranked 7,230th out of 14,666 executives tracked by ExecPay. In other words, Hager earned more than 50.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,230 out of 14,666 | 51st |
Division Manufacturing | 2,688 out of 5,772 | 53rd |
Major group Chemicals And Allied Products | 879 out of 2,075 | 58th |
Industry group Drugs | 687 out of 1,731 | 60th |
Industry Pharmaceutical Preparations | 540 out of 1,333 | 60th |
Source: SEC filing on April 27, 2018.
Hager's colleagues
We found four more compensation records of executives who worked with Alicia Hager at OncoMed Pharmaceuticals in 2017.